154 related articles for article (PubMed ID: 35297648)
1. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.
Huepenbecker SP; Zhao H; Sun CC; Fu S; He W; Giordano SH; Meyer LA
JCO Clin Cancer Inform; 2022 Mar; 6():e2100187. PubMed ID: 35297648
[TBL] [Abstract][Full Text] [Related]
2. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
4. Classifying Stage IV Lung Cancer From Health Care Claims: A Comparison of Multiple Analytic Approaches.
Brooks GA; Bergquist SL; Landrum MB; Rose S; Keating NL
JCO Clin Cancer Inform; 2019 May; 3():1-19. PubMed ID: 31070985
[TBL] [Abstract][Full Text] [Related]
5. External validation of a claims-based algorithm for classifying kidney-cancer surgeries.
Miller DC; Saigal CS; Warren JL; Leventhal M; Deapen D; Banerjee M; Lai J; Hanley J; Litwin MS
BMC Health Serv Res; 2009 Jun; 9():92. PubMed ID: 19500395
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data.
Beyrer J; Nelson DR; Sheffield KM; Huang YJ; Ellington T; Hincapie AL
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1465-1479. PubMed ID: 33012044
[TBL] [Abstract][Full Text] [Related]
7. Identifying incident oral and pharyngeal cancer cases using Medicare claims.
Mahnken JD; Keighley JD; Girod DA; Chen X; Mayo MS
BMC Oral Health; 2013 Jan; 13():1. PubMed ID: 23280327
[TBL] [Abstract][Full Text] [Related]
8. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
9. Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer.
Bronson MR; Kapadia NS; Austin AM; Wang Q; Feskanich D; Bynum JPW; Grodstein F; Tosteson ANA
Med Care; 2018 Dec; 56(12):e83-e89. PubMed ID: 29334524
[TBL] [Abstract][Full Text] [Related]
10. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
11. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.
Fenton JJ; Onega T; Zhu W; Balch S; Smith-Bindman R; Henderson L; Sprague BL; Kerlikowske K; Hubbard RA
Med Care; 2016 Mar; 54(3):e15-22. PubMed ID: 23929404
[TBL] [Abstract][Full Text] [Related]
12. Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis.
Vogel TJ; Jeon C; Karlan B; Walsh C
Gynecol Oncol; 2016 Feb; 140(2):285-8. PubMed ID: 26691221
[TBL] [Abstract][Full Text] [Related]
13. The Design and Validation of a New Algorithm to Identify Incident Fractures in Administrative Claims Data.
Wright NC; Daigle SG; Melton ME; Delzell ES; Balasubramanian A; Curtis JR
J Bone Miner Res; 2019 Oct; 34(10):1798-1807. PubMed ID: 31170317
[TBL] [Abstract][Full Text] [Related]
14. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
15. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer.
Thrall MM; Gray HJ; Symons RG; Weiss NS; Flum DR; Goff BA
Gynecol Oncol; 2011 Dec; 123(3):461-6. PubMed ID: 21945309
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases.
Dawwas GK; Weiss A; Constant BD; Parlett LE; Haynes K; Yang JY; Brensinger C; Wu Q; Pate V; Jonsson Funk M; Schaubel DE; Hurtado-Lorenzo A; David Kappelman M; Lewis JD
Inflamm Bowel Dis; 2023 Dec; 29(12):1993-1996. PubMed ID: 37043675
[TBL] [Abstract][Full Text] [Related]
18. An approach to identifying incident breast cancer cases using Medicare claims data.
Freeman JL; Zhang D; Freeman DH; Goodwin JS
J Clin Epidemiol; 2000 Jun; 53(6):605-14. PubMed ID: 10880779
[TBL] [Abstract][Full Text] [Related]
19. The utility of Medicare claims data for measuring cancer stage.
Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
